ALZHEIMER’S DISEASE AND OPPORTUNITY FOR POLICY CHANGE
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Amidst the introduction of breakthroughs to slow the progression of Alzheimer’s Disease, hesitation remains among people living with dementia and their care partners. Currently, over 7 million Americans are impacted by Alzheimer’s Disease and another 11 million Americans provide unpaid care for someone living with the disease. Despite the immense efforts made to develop treatments for those diagnosed, barriers in accessibility remain. As a GSA policy intern, I attended multiple coalition meetings centered around advocating for equitable access to new treatment options. I also analyzed legislation aimed at improving early detection, delaying disease progression, and improving access to treatments for people with Alzheimer’s disease and related dementias (ADRD). While following the work of agencies including, the Centers for Medicare and Medicaid Services (CMS), I found that noteworthy progress has been made in terms of coverage expansion, but GSA and other organizations will need to continue to advocate for those older adults who have been left out of the equation. It is important to recognize the considerable progress that has been made and the immense efforts in support of people affected by this disease and their care partners; however, it is evident that Alzheimer’s Disease must remain at the forefront of bipartisan policy initiatives to ensure that legislation is passed, and these barriers are alleviated.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- ALZHEIMER’S DISEASE AND OPPORTUNITY FOR POLICY CHANGE
- Date Crossref
- 01/12/2023
- Éditeur
- Oxford University Press (OUP)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.